It is now accepted that HIF‐1α is the primary driving force of the metabolic reprogramming seen in cancer cells, and constitutive activation of HIF‐1α resets the metabolic phenotype of the cell towards aerobic glycolysis by stimulating the glycolytic gene‐expression program.51 This evidence concerns the gene HIF1A and cancer.